Coronary revascularisation in people with multiple long-term conditions: a systematic review and meta-analysis

Abstract

IntroductionPeople presenting for multivessel coronary revascularisation commonly have multiple long-term conditions that influence prognosis. The aim of this study was to review the evidence for revascularisation choices in these groups.

MethodsRandomised trials of Coronary Artery Bypass Grafting (CABG) versus Percutaneous Coronary Intervention (PCI) reporting outcomes by pre-specified comorbidities were included. Treatment effects were estimated using inverse variance random effects models and presented as Risk Ratios (95% Confidence Intervals). The certainty of evidence for outcomes was assessed using Grading of Recommendations Assessment, Development and Evaluation (GRADE).

Results19 studies from nine RCTs with 10,594 participants were included. Reported baseline comorbidities included diabetes (49%), CKD (25%), LVSD (9%), female sex (14%), and older age (40%). Trials were unblinded, resulting in some bias concerns. For people with diabetes and CKD, CABG reduced the risks of all-cause death and repeat revascularisation, with no treatment effect on MI or stroke, versus PCI. There was no difference in mortality or stroke for female sex, or older age. No data was reported for people with peripheral vascular disease or frailty. Patient reported outcomes favoured CABG in people with diabetes. GRADE showed that the certainty of the evidence was generally Low to Very Low with the exception of people with diabetes (Moderate Certainty).

ConclusionThere is a knowledge gap with respect to the risks and benefits of CABG versus PCI in people with common comorbidities.

RegistrationPROSPERO CRD420251032665

The Efficacy and Safety of Dalfampridine on Cognition and Fatigue in People With Multiple Sclerosis: A Systematic Review and Meta-Analysis
Mumen H. Halabi, Rakan Alromayan, Maram Almutairi +3
International Journal of MS Care2 Nov 2026Peer-reviewedLicence not statedFull textGeneral medicinePMC
Disparities in treatment burden in Peru among people with multiple long-term conditions by geography and healthcare facility: A cross-sectional study
Silvana Perez-Leon, Daniel Mendoza-Quispe, Maria Sofia Cuba-Fuentes +11
PLOS Global Public Health29 Sep 2026Peer-reviewedCC BY 4.0Full textEpidemiology & public healthPLOS
‘People need to be a bit more understanding that my body is wrecked’: A qualitative exploration of inpatient hospital care for people living with multiple long-term conditions
Sue Bellass, Thomas Scharf, Miles D Witham +5
BMC Medicine16 Oct 2026Peer-reviewedCC BY 4.0Full text1 citedEpidemiology & public healthCrossref
People living with multiple long-term conditions have different pathways of unscheduled care in hospital: findings from an analysis of routinely-collected clinical data
M. Witham, F. Evison, S. Bellass +6
medRxiv28 Aug 2026PreprintCC BYFull textEpidemiology & public healthmedRxiv
Front-line decision-making: a thematic analysis of interviews with hospital staff on referrals, admissions, and care for people with multiple long-term conditions
Sara Pretorius, Sue Bellass, Rachel Cooper +9
BMC Medicine16 Oct 2026Peer-reviewedCC BY 4.0Full text1 citedEpidemiology & public healthCrossref

Cite

BibTeX RIS

BibTeX

@misc{cheng2026coronary,
  title = {{Coronary revascularisation in people with multiple long-term conditions: a systematic review and meta-analysis}},
  author = {A. Cheng and A. Alhashimi and C. J. Lim and S. C. Cheong and H. Shahbaz and R. Abbasciano and M. Pufulete and G. J. Murphy},
  howpublished = {medRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.04.26362027},
  url = {https://www.medrxiv.org/content/10.64898/2026.09.04.26362027v1},
  note = {CC BY},
}

RIS

TY  - UNPB
TI  - Coronary revascularisation in people with multiple long-term conditions: a systematic review and meta-analysis
AU  - A. Cheng
AU  - A. Alhashimi
AU  - C. J. Lim
AU  - S. C. Cheong
AU  - H. Shahbaz
AU  - R. Abbasciano
AU  - M. Pufulete
AU  - G. J. Murphy
PY  - 2026
DA  - 2026/09/04
PB  - medRxiv
DO  - 10.64898/2026.09.04.26362027
UR  - https://www.medrxiv.org/content/10.64898/2026.09.04.26362027v1
AB  - IntroductionPeople presenting for multivessel coronary revascularisation commonly have multiple long-term conditions that influence prognosis. The aim of this study was to review the evidence for revascularisation choices in these groups.  MethodsRandomised trials of Coronary Artery Bypass Grafting (CABG) versus Percutaneous Coronary Intervention (PCI) reporting outcomes by pre-specified comorbidities were included. Treatment effects were estimated using inverse variance random effects models and presented as Risk Ratios (95% Confidence Intervals). The certainty of evidence for outcomes was assessed using Grading of Recommendations Assessment, Development and Evaluation (GRADE).  Results19 studies from nine RCTs with 10,594 participants were included. Reported baseline comorbidities included diabetes (49%), CKD (25%), LVSD (9%), female sex (14%), and older age (40%). Trials were unblinded, resulting in some bias concerns. For people with diabetes and CKD, CABG reduced the risks of all-cause death and repeat revascularisation, with no treatment effect on MI or stroke, versus PCI. There was no difference in mortality or stroke for female sex, or older age. No data was reported for people with peripheral vascular disease or frailty. Patient reported outcomes favoured CABG in people with diabetes. GRADE showed that the certainty of the evidence was generally Low to Very Low with the exception of people with diabetes (Moderate Certainty).  ConclusionThere is a knowledge gap with respect to the risks and benefits of CABG versus PCI in people with common comorbidities.  RegistrationPROSPERO CRD420251032665
ER  -

Abstract

Related

Cite